|
| 36865297 | Enhancer profiling identifies epigenetic markers of endocrine resistance and reveals therapeutic options for metastatic castration-resistant prostate cancer patients. | medRxiv | 2023 |
| 37271632 | Grade Group 1 Prostate Cancers Exhibit Tumor-defining Androgen Receptor-driven Programs. | Eur Urol | 2023 |
| 37070193 | PAXIP1 and STAG2 converge to maintain 3D genome architecture and facilitate promoter/enhancer contacts to enable stress hormone-dependent transcription. | Nucleic Acids Res | 2023 |
| 36107780 | Double-strand break toxicity is chromatin context independent. | Nucleic Acids Res | 2022 |
| 35509021 | Androgen receptor reprogramming demarcates prognostic, context-dependent gene sets in primary and metastatic prostate cancer. | Clin Epigenetics | 2022 |
| 35754340 | Drug-Induced Epigenomic Plasticity Reprograms Circadian Rhythm Regulation to Drive Prostate Cancer toward Androgen Independence. | Cancer Discov | 2022 |
| 36450752 | Extensive androgen receptor enhancer heterogeneity in primary prostate cancers underlies transcriptional diversity and metastatic potential. | Nat Commun | 2022 |
| 33452241 | The circadian cryptochrome, CRY1, is a pro-tumorigenic factor that rhythmically modulates DNA repair. | Nat Commun | 2021 |
| 33576154 | Epigenetic and transcriptional analysis reveals a core transcriptional program conserved in clonal prostate cancer metastases. | Mol Oncol | 2021 |
| 34737261 | Opposing transcriptional programs of KLF5 and AR emerge during therapy for advanced prostate cancer. | Nat Commun | 2021 |
| 34272384 | Glucocorticoid receptor triggers a reversible drug-tolerant dormancy state with acquired therapeutic vulnerabilities in lung cancer. | Nat Commun | 2021 |
| 32484599 | The MSP-RON axis stimulates cancer cell growth in models of triple negative breast cancer. | Mol Oncol | 2020 |
| 31974375 | Noncoding mutations target cis-regulatory elements of the FOXA1 plexus in prostate cancer. | Nat Commun | 2020 |
| 32690948 | Prostate cancer reactivates developmental epigenomic programs during metastatic progression. | Nat Genet | 2020 |
| 30514804 | Lysine specific demethylase 1 inactivation enhances differentiation and promotes cytotoxic response when combined with all-<i>trans</i> retinoic acid in acute myeloid leukemia across subtypes. | Haematologica | 2019 |
| 31797935 | CD4<sup>+</sup> T cell help creates memory CD8<sup>+</sup> T cells with innate and help-independent recall capacities. | Nat Commun | 2019 |
| 31735626 | Cistrome Partitioning Reveals Convergence of Somatic Mutations and Risk Variants on Master Transcription Regulators in Primary Prostate Tumors. | Cancer Cell | 2019 |
| 31036541 | EZH2 Is Overexpressed in <i>BRCA1</i>-like Breast Tumors and Predictive for Sensitivity to High-Dose Platinum-Based Chemotherapy. | Clin Cancer Res | 2019 |
| 29396493 | Characterizing steroid hormone receptor chromatin binding landscapes in male and female breast cancer. | Nat Commun | 2018 |
| 30041599 | Mitotic count can predict tamoxifen benefit in postmenopausal breast cancer patients while Ki67 score cannot. | BMC Cancer | 2018 |
| 30524905 | Assessment of PD-L1 expression across breast cancer molecular subtypes, in relation to mutation rate, <i>BRCA1</i>-like status, tumor-infiltrating immune cells and survival. | Oncoimmunology | 2018 |
| 29719599 | Fanconi anemia and homologous recombination gene variants are associated with functional DNA repair defects <i>in vitro</i> and poor outcome in patients with advanced head and neck squamous cell carcinoma. | Oncotarget | 2018 |
| 29760405 | ARID1A mutation sensitizes most ovarian clear cell carcinomas to BET inhibitors. | Oncogene | 2018 |
| 28062545 | A review of estrogen receptor/androgen receptor genomics in male breast cancer. | Endocr Relat Cancer | 2017 |
| 28948212 | DNA repair deficiency biomarkers and the 70-gene ultra-high risk signature as predictors of veliparib/carboplatin response in the I-SPY 2 breast cancer trial. | NPJ Breast Cancer | 2017 |
| 28851423 | The BRCA1ness signature is associated significantly with response to PARP inhibitor treatment versus control in the I-SPY 2 randomized neoadjuvant setting. | Breast Cancer Res | 2017 |
| 26729235 | Integration of genomic, transcriptomic and proteomic data identifies two biologically distinct subtypes of invasive lobular breast cancer. | Sci Rep | 2016 |
| 27197147 | Comparative Cistromics Reveals Genomic Cross-talk between FOXA1 and ERα in Tamoxifen-Associated Endometrial Carcinomas. | Cancer Res | 2016 |
| 27129152 | Neoadjuvant tamoxifen synchronizes ERα binding and gene expression profiles related to outcome and proliferation. | Oncotarget | 2016 |
| 26004083 | BRCA1-like signature in triple negative breast cancer: Molecular and clinical characterization reveals subgroups with therapeutic potential. | Mol Oncol | 2015 |
| 25825120 | Robust BRCA1-like classification of copy number profiles of samples repeated across different datasets and platforms. | Mol Oncol | 2015 |
| 24467828 | PIK3CA mutations, phosphatase and tensin homolog, human epidermal growth factor receptor 2, and insulin-like growth factor 1 receptor and adjuvant tamoxifen resistance in postmenopausal breast cancer patients. | Breast Cancer Res | 2014 |
| 24447434 | Phosphorylated p-70S6K predicts tamoxifen resistance in postmenopausal breast cancer patients randomized between adjuvant tamoxifen versus no systemic treatment. | Breast Cancer Res | 2014 |
| 22249354 | Novel mRNA isoforms and mutations of uridine monophosphate synthetase and 5-fluorouracil resistance in colorectal cancer. | Pharmacogenomics J | 2013 |
| 23736997 | CYP2C19 2 predicts substantial tamoxifen benefit in postmenopausal breast cancer patients randomized between adjuvant tamoxifen and no systemic treatment. | Breast Cancer Res Treat | 2013 |
| 21796119 | Frequent mutation of histone-modifying genes in non-Hodgkin lymphoma. | Nature | 2011 |
| 20081860 | Somatic mutations altering EZH2 (Tyr641) in follicular and diffuse large B-cell lymphomas of germinal-center origin. | Nat Genet | 2010 |
| 21129721 | Hypomorphic temperature-sensitive alleles of NSDHL cause CK syndrome. | Am J Hum Genet | 2010 |
| 20696054 | Evolution of an adenocarcinoma in response to selection by targeted kinase inhibitors. | Genome Biol | 2010 |
| 20884631 | Acquired TNFRSF14 mutations in follicular lymphoma are associated with worse prognosis. | Cancer Res | 2010 |
| 19812674 | Mutational evolution in a lobular breast tumour profiled at single nucleotide resolution. | Nature | 2009 |
| 18493019 | A novel DNA sequence database for analyzing human demographic history. | Genome Res | 2008 |
| 15483323 | Evidence for archaic Asian ancestry on the human X chromosome. | Mol Biol Evol | 2005 |
| 12454039 | Expression profile and genome location of cDNA clones from an infant human trabecular meshwork cell library. | Invest Ophthalmol Vis Sci | 2002 |